Memantine as a Supplement to Naltrexone in Treating Heroin Dependence

Clinical trial NCT00476242 · COMPLETED

Trial details

NCT number: NCT00476242
Sponsor: New York State Psychiatric Institute
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Opioid Dependence Heroin Dependence

Start date: 2008-06-01
Primary completion: 2011-08-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.